Breast cancer: new aspects of adjuvant hormonal therapy.
作者信息
Lohrisch C, Piccart M
机构信息
Investigational Drug Branch for Breast Cancer, EORTC, Brussels, Belgium.
出版信息
Ann Oncol. 2000;11 Suppl 3:13-25. doi: 10.1093/annonc/11.suppl_3.13.
PMID:11079114
Abstract
摘要
相似文献
1
Breast cancer: new aspects of adjuvant hormonal therapy.
Ann Oncol. 2000;11 Suppl 3:13-25. doi: 10.1093/annonc/11.suppl_3.13.
2
Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
J Surg Oncol. 2006 Jun 1;93(7):585-92. doi: 10.1002/jso.20564.
3
[Sensitivity of chemotherapy depending on hormone status in breast cancer].
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:568-71.
4
[Adjuvant treatment of breast cancer. Endocrine therapy].
Ugeskr Laeger. 2007 Sep 10;169(37):3072-6.
5
Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?
Nat Clin Pract Oncol. 2004 Nov;1(1):24-5. doi: 10.1038/ncponc0021.
6
Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
J Clin Pharm Ther. 2005 Aug;30(4):313-7. doi: 10.1111/j.1365-2710.2005.00655.x.
7
The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
Eur J Cancer. 2005 Aug;41(12):1678-89. doi: 10.1016/j.ejca.2004.10.020. Epub 2004 Nov 25.
8
Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
J Clin Oncol. 2005 Aug 1;23(22):4850-2. doi: 10.1200/JCO.2005.03.904. Epub 2005 Jul 11.
9
Advances in adjuvant hormonal therapy for postmenopausal women.
J Clin Oncol. 2005 Mar 10;23(8):1751-9. doi: 10.1200/JCO.2005.11.038.
10
[Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
Ugeskr Laeger. 2007 Jan 22;169(4):297-9.
引用本文的文献
1
Association between breast cancer chemotherapy, oral health and chronic dental infections: a pilot study.
Odontology. 2019 Jul;107(3):401-408. doi: 10.1007/s10266-019-00411-z. Epub 2019 Jan 21.
Zotero 插件